Global Percutaneous Transluminal Angioplasty Balloons Market Outlook 2031: Valued at US$ 2.1 Bn in 2022, Expected to Reach Over US$ 3.5 Bn by 2031

The global percutaneous transluminal angioplasty (PTA) balloons market was valued at approximately US$ 2.1 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 5.4%, reaching more than US$ 3.5 billion by 2031. This growth is largely driven by the increasing prevalence of cardiovascular diseases (CVDs), the rising demand for minimally invasive procedures, and advancements in PTA balloon technology.

Download to explore critical insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=39368

Introduction to Percutaneous Transluminal Angioplasty

Percutaneous Transluminal Angioplasty (PTA) is a minimally invasive procedure used primarily to treat cardiovascular diseases such as atherosclerosis, coronary artery disease, and peripheral artery disease. It involves the insertion of a balloon catheter into narrowed or blocked blood vessels to widen them, restoring proper blood flow. This technique is considered safer and more effective than traditional surgeries, offering faster recovery times, lower complication rates, and the possibility of outpatient procedures.

Factors Driving Market Growth

1. Increasing Cardiovascular Disease Prevalence: CVDs remain the leading cause of death globally. According to the World Health Organization (WHO), nearly 18 million people succumb to CVDs every year. The growing incidence of these diseases, attributed to an aging population, poor lifestyles, obesity, and diabetes, is expected to significantly drive the demand for PTA balloons.
2. Preference for Minimally Invasive Procedures: The shift towards minimally invasive procedures is accelerating, as PTA balloons allow for smaller incisions, reduced recovery times, and lower risk of complications compared to traditional surgery. This makes PTA a highly attractive option for both patients and healthcare providers.
3. Technological Advancements in PTA Balloons: Continuous innovations in PTA balloon technology, such as the development of drug-eluting balloons and cutting and scoring balloons, are improving the safety, precision, and efficacy of the procedure. These advancements are making PTA an increasingly viable option for a wider range of patients.

Market Segmentation

1. By Product:
• Conventional Balloons: These are non-coated and the most widely used PTA balloons. They are known for their cost-effectiveness, ease of use, and compatibility with various blood vessels. As a result, conventional balloons are expected to dominate the market during the forecast period.
• Drug-Eluting Balloons: These balloons are coated with medication to prevent the re-narrowing of blood vessels after the procedure.
• Cutting and Scoring Balloons: These balloons have built-in mechanisms to cut through hardened plaque, making them ideal for tougher blockages.
2. By Guidewire Compatibility:
• 0.014 Inch: This is the most popular guidewire size, offering high maneuverability and compatibility with small and tortuous blood vessels, especially in peripheral and coronary angioplasty procedures.
• 0.018 Inch and 0.035 Inch: These guidewires are also widely used, with the 0.035 inch being suitable for larger vessels and more complex cases.
3. By Application:
• Coronary Angioplasty: The treatment of coronary artery disease remains the largest application segment for PTA balloons. Coronary angioplasty is the most common use of PTA balloons, driven by the increasing prevalence of heart disease.
• Peripheral Angioplasty: PTA balloons are also used to treat peripheral artery disease, which is becoming more prevalent due to aging populations and lifestyle factors.
4. By End-User:
• Hospitals: Hospitals are expected to remain the largest end-user for PTA balloons, given their advanced infrastructure and the availability of specialized equipment and trained professionals.
• Ambulatory Surgical Centers (ASCs) and Specialty Clinics: ASCs and specialty clinics are increasingly adopting PTA balloons due to their ability to offer cost-effective and minimally invasive treatments.

Visit our report to explore critical insights and analysis - https://www.transparencymarketresearch.com/percutaneous-transluminal-angioplasty-balloons-market.html

Regional Outlook

1. North America: This region is expected to dominate the PTA balloons market, owing to high healthcare expenditure, advanced healthcare infrastructure, and a strong presence of key market players. The U.S. in particular is a major growth engine for the industry due to increasing investment in R&D and the adoption of advanced technologies.
2. Asia Pacific: The Asia Pacific region is expected to witness the fastest growth during the forecast period. Factors such as a growing elderly population, rising healthcare investments, and a high prevalence of cardiovascular diseases are driving the demand for PTA balloons in this region.
3. Europe: Europe is also a significant market for PTA balloons, with countries like Germany, the U.K., and France investing heavily in advanced medical technologies.

Key Players in the Market

The PTA balloons market features key players who are focusing on product innovations and expanding their market presence:

• Abbott
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Cook Medical
• Cordis
• Medtronic
• MicroPort Scientific Corporation
• Opto Circuits (India) Ltd.
• Spectranetics (Philips Healthcare)
• Terumo Corporation

These companies are heavily investing in R&D to enhance the performance of PTA balloons and ensure their compatibility with advanced medical devices, thereby improving the outcomes of cardiovascular procedures.

Recent Developments

• SIS Medical AG launched the OPN NC PTA Dilatation Catheter with Twin-Wall technology in February 2023, which offers improved durability and performance.
• BrosMed Medical received 510(k) clearance from the U.S. FDA for its Tiche 0.035" PTA Balloon Dilatation Catheter in 2022, expanding their product offering in the PTA balloon segment.

Conclusion

The global percutaneous transluminal angioplasty balloons market is poised for significant growth, driven by technological advancements, the increasing burden of cardiovascular diseases, and the rise in preference for minimally invasive procedures. With ongoing R&D and increasing adoption of PTA balloons across regions, the market is expected to expand substantially over the next decade, offering numerous opportunities for market players and healthcare providers.

Examine key highlights and takeaways from our Report in this sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=39368   

Explore Latest Research Reports:

Sterilization Wrap Market - The global industry was valued at US$ 374.8 Mn in 2022. It is expected to grow at a CAGR of 4.5% from 2023 to 2031 and reach US$ 564.5 Mn by the end of 2031.

Antimicrobial Ingredients Market - The global industry was valued at US$ 5.5 Bn in 2022. It is estimated to grow at a CAGR of 4.3% from 2023 to 2031 and reach US$ 8.1 Bn by the end of 2031.

Cardiac Resynchronization Therapy Systems Market - The global industry was valued at US$ 4.5 Bn in 2022. It is estimated to grow at a CAGR of 4.9% from 2023 to 2031 and reach US$ 6.9 Bn by the end of 2031.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com    
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube